Clinical Trial Update: Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated diclofenac sodium topical gel to reduce injection-site discomfort in multiple sclerosis patients treated with glatiramer acet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Diclofenac Sodium Topical Gel (diclofenac)
• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: Brown, Theodore R., M.D., MPH | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2015-02-13